Treating hypertension in Black patients

Document Type

Article

Publication Title

Journal of the American Academy of PAs

Abstract

Abstract

For the first time in its history, the Eighth Joint National Committee (JNC-8) published hypertension guidelines that varied depending on patient race, with different treatment recommendations for Black and non-Black patients. Although initial therapy in non-Black patients is to be carried out with one of four agents—thiazide diuretics, calcium channel blockers, angiotensin-converting enzyme (ACE) inhibitors, or angiotensin receptor blockers (ARBs)—the recommendation for Black patients removed ACE inhibitors and ARBs from the algorithm. This article reviews some of the physiologic theories for the difference in recommendations and discusses potential complications with race-based treatment algorithms.

First Page

15

Last Page

18

DOI

10.1097/01.JAA.0000791512.37549.64

Publication Date

2-2022

Comments

Gardner, Nathan J. DMSc, PA-C. Treating hypertension in Black patients. JAAPA 35(2):p 15-18, February 2022.

DOI: 10.1097/01.JAA.0000791512.37549.64

Link to Full Text

Share

COinS